Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Precision Panc, a platform for pancreatic cancer

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 06.12.17
Views: 965

Prof Andrew Biankin - University of Glasgow, Glasgow, UK

Andrew Biankin talks to ecancer at EAPM 2017 in Belfast.

Pancreatic cancer is the 3rd leading cause of cancer death in Europe and US.

Prof Biankin discusses Precision Panc, which is a platform to share and disseminate data and information about pancreatic cancer that will improve the pathway to successful treatment.

There's a clinical trail option called PRIMUS which finds the right trial for the patient by using data from a sample of their tumour. 

He discusses the problems with lower incidence cancers such as pancreatic cancers.  

Related videos

follow us

Donate to ecancer

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation